Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 23
Phase 31

Trial Status

Recruiting4

Role Distribution

Other Roles4

Activity Timeline

Clinical Trials (4)

NCT06601309Phase 2Recruiting
Biomarker Based Neoadjuvant Strategies for Locally Advanced Resectable ESCC
Esophageal Squamous Cell Carcinoma
StudydirectorStart date: 2024-07-11
NCT06510660Phase 2Recruiting
Adebrelimab ±Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Unresectable Locally Advanced ESCC
BiomarkersEsophageal Squamous Cell CarcinomaImmunotherapy
StudydirectorStart date: 2024-04-11

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT06559696Phase 3StudyDirector

Internal Mammary Lymph Nodes Irradiation in High-risk Breast Cancer After Neoadjuvant Chemotherapy

Breast Cancer
Recruiting
NCT06601309Phase 2StudyDirector

Biomarker Based Neoadjuvant Strategies for Locally Advanced Resectable ESCC

Esophageal Squamous Cell Carcinoma
Recruiting
NCT06510660Phase 2StudyDirector

Adebrelimab ±Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Unresectable Locally Advanced ESCC

BiomarkersEsophageal Squamous Cell CarcinomaImmunotherapy
Recruiting
NCT05704166Phase 2StudyDirector

PirfenidoneVsPlacebo as Prophylaxis Against Acute Radiation-induced Lung Injury Following HFRT in Breast Cancer Patients

Acute Lung InjuryPrevention
Recruiting

All 4 trials loaded